...
机译:他汀类药物使用和新出售糖尿病的风险:观察研究的荟萃分析
Epidemiology and Preventive Pharmacology Centre (SEFAP) Department of Pharmacological and;
Epidemiology and Preventive Pharmacology Centre (SEFAP) Department of Pharmacological and;
Department of Statistics and Quantitative Methods Division of Biostatistics Epidemiology and;
Epidemiology and Preventive Pharmacology Centre (SEFAP) Department of Pharmacological and;
Center for the Study of Atherosclerosis E. Bassini Hospital;
Department of Statistics and Quantitative Methods Division of Biostatistics Epidemiology and;
Epidemiology and Preventive Pharmacology Centre (SEFAP) Department of Pharmacological and;
Statins; Incident diabetes; Meta-analysis; Observational studies;
机译:他汀类药物使用和新出售糖尿病的风险:观察研究的荟萃分析
机译:用他汀类药物治疗的低密度脂蛋白胆固醇减少与新发病糖尿病的风险:META分析
机译:特征相关2型糖尿病风险的异质性证据:随机对照试验和观察研究的荟萃分析
机译:2型糖尿病发病预测的重新校准模型的重要性:糖尿病人群风险工具在健康和退休研究中的应用
机译:患有2型糖尿病患者的新抗血糖药物的任何低血糖症的风险:系统审查和荟萃分析
机译:他汀类药物治疗降低低密度脂蛋白胆固醇与新发糖尿病风险之间的关联:一项荟萃分析
机译:他汀类药物使用和新出售糖尿病的风险:荟萃分析观察研究
机译:出生体重和急性儿童白血病:观察性研究的meta分析